BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.12.0//EN
X-ORIGINAL-URL:https://ipacanada.com/
X-WR-CALNAME:IPA
X-WR-CALDESC:
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-58238e9ae2dd305d79c2ebc8c1883422@ipacanada.com
DTSTART:20201021T040000Z
DTEND:20201022T040000Z
DTSTAMP:20191213T140000Z
CREATED:20191213
LAST-MODIFIED:20201018
PRIORITY:5
SEQUENCE:0
TRANSP:OPAQUE
SUMMARY:DAY 1 -Stability Program Conference
DESCRIPTION:We are delighted to announce IPA ‘s Stability Program Conference taking place on October 20-21, 2020 in Toronto Canada.\nThis interactive and comprehensive conference will provide attendees in learning how to establish the most effective, compliant, and improving your stability program from early stage development to commercial products. This includes latest regulatory compliance updates, scientific discoveries, technologies and innovations in the pharmaceutical, biopharmaceutical and allied industries.\nConfirmed Speakers include:\nDr. Geoff Carr, Director, Analytical Development, Ontario, Patheon, by Thermo Fisher Scientific\nDr. Kristina Flavier, Sr. Scientist, FreeThink Technologies, Inc.\nChristopher (Chris) V. Latoz , Stability Manager, Hollister Incorporated\nDr. Peter Tattersall, Senior Principal Scientist in Chemical and Synthetic Development within Pharmaceutical Development, Bristol-Myers Squibb Company\nEmily S. D. Trubee, MS, Stability Manager, R&D, Adare Pharmaceuticals\nAnd more to come!\nMark your calendar! Stay tuned for our full program details. To receive more information, please Click here. ( mailto:enquiry@ipacanada.com?subject=Request More Details on Stability Program Conference )\n \n
URL:https://ipacanada.com/Stability_2020/index.html
ORGANIZER;CN=IPA Conference:MAILTO:
CATEGORIES:Conference
LOCATION:Virtual Event
ATTACH;FMTTYPE=image/jpeg:https://i0.wp.com/ipacanada.com/wp-content/uploads/2019/12/pills.jpg?fit=1200%2C400&ssl=1
END:VEVENT
END:VCALENDAR